ATE221078T1 - Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung - Google Patents

Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung

Info

Publication number
ATE221078T1
ATE221078T1 AT99306612T AT99306612T ATE221078T1 AT E221078 T1 ATE221078 T1 AT E221078T1 AT 99306612 T AT99306612 T AT 99306612T AT 99306612 T AT99306612 T AT 99306612T AT E221078 T1 ATE221078 T1 AT E221078T1
Authority
AT
Austria
Prior art keywords
azithromycin
isopropanol
clathrates
production
methods
Prior art date
Application number
AT99306612T
Other languages
English (en)
Inventor
Khashayar Karimian
Mehrnoush Motamedi
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Application granted granted Critical
Publication of ATE221078T1 publication Critical patent/ATE221078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99306612T 1998-08-21 1999-08-20 Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung ATE221078T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002245398A CA2245398C (en) 1998-08-21 1998-08-21 Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof

Publications (1)

Publication Number Publication Date
ATE221078T1 true ATE221078T1 (de) 2002-08-15

Family

ID=4162751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99306612T ATE221078T1 (de) 1998-08-21 1999-08-20 Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung

Country Status (5)

Country Link
US (2) US6245903B1 (de)
EP (1) EP0984020B1 (de)
AT (1) ATE221078T1 (de)
CA (1) CA2245398C (de)
DE (1) DE69902212T2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
CN1273142C (zh) * 1998-11-30 2006-09-06 特瓦制药工业有限公司 阿齐霉素的乙醇化物,制备方法以及医药组合物
AU5820400A (en) * 1999-06-29 2001-01-31 Biochemie S.A. Macrolides
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
ATE320441T1 (de) 2000-07-25 2006-04-15 Silanes Sa De Cv Lab Einstufiges verfahren zur herstellung von 7,16-
WO2002009640A2 (en) * 2000-08-01 2002-02-07 Shiva Prasad Singh Process for the preparation of anhydrous azithromycin
DE60114028T2 (de) * 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
US6949519B2 (en) 2000-11-27 2005-09-27 Sandoz Ag Macrolide solvates
CN100341886C (zh) * 2000-11-27 2007-10-10 桑多斯股份公司 大环内酯类化合物的溶剂化物
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
EP1671979B1 (de) * 2001-05-22 2008-08-13 Pfizer Products Inc. Neue Kristallforme von Azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
NZ529118A (en) 2001-05-22 2005-10-28 Pfizer Prod Inc Crystal forms of azithromycin
NZ532707A (en) * 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
IL161259A0 (en) * 2001-12-21 2004-09-27 Pfizer Prod Inc Methods for wet granulating azithromycin
NZ534234A (en) * 2002-02-01 2007-05-31 Pfizer Prod Inc Dry granulated formulations of non-dihydrate form of azithromycin
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
CA2422972A1 (en) * 2003-03-21 2004-09-21 Apotex Inc. Isopropanolate of azithromycin and method of manufacturing
WO2005002592A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Stable oral compositions of azithromycin monohydrate
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1648473B1 (de) 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Schnellösliches azithromycin in einzeldosisform
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
CN1889932A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 制备药用多颗粒的方法
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
EP1689368B1 (de) * 2003-12-04 2016-09-28 Bend Research, Inc Sprüherstarrungsverfahren mit einem extruder zur herstellung von multiteilchenförmigen kristallinen arzneimittelzusammensetzungen
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006011160A1 (en) * 2004-06-28 2006-02-02 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
US20090130154A1 (en) * 2004-08-26 2009-05-21 Bioderm Research Topical Delivery of Biological and Cosmetic Agents by Zeolites
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
BRPI1009823A2 (pt) 2009-03-13 2019-09-24 Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
CN102712670A (zh) 2009-12-18 2012-10-03 西北大学 包含无定形晶状玻璃态阿奇霉素的组合物
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
JPS58157790A (ja) 1982-03-16 1983-09-19 Takeda Chem Ind Ltd ７−デアザプリン誘導体およびその製造法
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
CA1202619A (en) 1982-07-19 1986-04-01 Gene M. Bright Intermediates for the preparation of n-methyl 11-aza- 10-deoxo-10-dihydroerythromycin a
UA27040C2 (uk) 1987-07-09 2000-02-28 Пфайзер Інк. Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
CN1093370A (zh) 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
US5808017A (en) * 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
DK0915899T3 (da) 1996-07-29 2004-11-29 Abbott Lab Fremstilling af krystallinsk form II af clarithromycin
KR100378434B1 (ko) * 1997-07-08 2003-03-29 바이오케미 에스.에이. 에리트로마이신 ａ 옥심 용매화물
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
KR100377159B1 (ko) 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
CN1273142C (zh) 1998-11-30 2006-09-06 特瓦制药工业有限公司 阿齐霉素的乙醇化物,制备方法以及医药组合物
AU5820400A (en) 1999-06-29 2001-01-31 Biochemie S.A. Macrolides
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
USRE39087E1 (en) 2006-05-02
DE69902212D1 (de) 2002-08-29
EP0984020B1 (de) 2002-07-24
EP0984020A3 (de) 2000-10-04
US6245903B1 (en) 2001-06-12
CA2245398C (en) 2002-01-29
CA2245398A1 (en) 2000-02-21
EP0984020A2 (de) 2000-03-08
DE69902212T2 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
ATE221078T1 (de) Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung
CA2135138A1 (en) Method for producing formic acid or its derivatives
SE0001931D0 (sv) Metod vid tillverkning av en mall, samt mallen tillverkad därav
DE69637747D1 (de) Zuckerverbindungen
HK1054367A1 (en) Method for producing spherical activated carbon.
ATE425973T1 (de) Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur
WO2001057917A3 (en) System and method for fabricating logic devices comprising carbon nanotube transistors
MXPA03003533A (es) Metodo para producir una solucion que consiste en un polimero que contiene unidades azol recurrentes, soluciones producidas de acuerdo con dicho metodo y uso de las mismas.
HK1068813A1 (en) Method for the production of solid formulations of sodium 3-hydroxy-3- methylbutyrate
AR046065A1 (es) Cristales de penam y procedimiento para la produccion de los mismos
ID28892A (id) Sintesa heteropoliasida
WO2000076989A3 (de) Verfahren zur umsetzung organischer verbindungen mit wasserstoffperoxid
HUP9901713A2 (hu) Eljárás enantiomer-tiszta 2-azetidinkarbonsav előállítására
RU97108520A (ru) Способ получения полисиликатов натрия
EP1300391A4 (de) Verfahren zur produktion von 3-amino-2-hydroxypropionsäure-derivaten
EP1356825A4 (de) Verfahren zur herstellung einer wässrigen zellulosederivat-dispersion
FR2825362B1 (fr) Procede de fabrication de l'oxime de la 2,2,4,4-tetramethyl- 3-pentanone et de sels d'hydroxylammonium
NO20004636D0 (no) FremgangsmÕte for separering av difosfindiastereoisomerer
ATE257483T1 (de) Verfahren zur herstellung von perbenzylierten 1-o-glycosiden
PT859795E (pt) Processo para a preparacao de ferro-dextrano cristalino
AR036017A1 (es) Proceso para la preparacion de cilastatina sodica pura en una forma amorfa
TW200420620A (en) Manufacturing method of polymer with sulfoalkyl group
ATE397020T1 (de) Pharmazeutisch verwendbare stärke und deren herstellungsverfahren
HUP0302903A2 (hu) Eljárás királis vegyületek előállítására
KR960004204A (ko) 활성환 이산화염소 수용액의 제조방법